第1笔成交价格为28.09元，成交35.00万股，成交金额983.15万元，溢价率为-1.51%，买方营业部为机构 专用，卖方营业部为华泰证券股份有限公司南京中山东路华泰证券大厦证券营业部。 进一步统计，近3个月内该股累计发生7笔大宗交易，合计成交金额为5525.6万元。该股近5个交易日累 计上涨7.26%，主力资金合计净流出2092.94万元。 责任编辑：小浪快报 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 9月16日，奥精医疗收涨6.78%，收盘价为28.52元，发生1笔大宗交易，合计成交量35万股，成交金额 983.15万元。 ...

Group 1 - On September 16, Aojing Medical executed a block trade of 350,000 shares, with a transaction value of 9.8315 million yuan, accounting for 2.03% of the total transaction volume for that day [1] - The transaction price was 28.09 yuan, which represents a discount of 1.51% compared to the market closing price of 28.52 yuan [1]

截至2025年9月15日收盘，奥精医疗(688613)报收于26.71元，上涨3.13%，换手率9.04%，成交量12.38万 手，成交额3.36亿元。 公司公告汇总 北京市中伦律师事务所就奥精医疗科技股份有限公司2025年第二次临时股东大会出具法律意见书。本次 股东大会由公司董事会召集，于2025年9月15日14:30在北京市大兴区生物医药产业基地庆丰西路69号35 号楼3层召开，采用现场与网络投票相结合方式。会议审议通过了《关于补选第二届董事会非独立董事 的议案》。出席本次股东大会的股东及授权代理人共48名，代表有表决权股份数21,634,885股，占股权 登记日总股本的15.7908%。会议召集、召开程序、出席人员及召集人资格、表决程序及表决结果均符 合《公司法》《股东会规则》及《公司章程》规定，表决结果合法有效。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 来自交易信息汇总：9月15日主力资金净流入1609.83万元，占总成交额4.79%。 来自交易信息汇总：当日发生1笔大宗交易，机构净买入920.85万元。 来自公司公 ...

本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东大会召开的时间：2025 年 9 月 15 日 证券代码：688613 证券简称：奥精医疗 公告编号：2025-051 奥精医疗科技股份有限公司 2025年第二次临时股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： （二） 股东大会召开的地点：北京市大兴区庆丰西路 69 号 35 号楼 3 层 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 48 | | --- | --- | | 普通股股东人数 | 48 | | 2、出席会议的股东所持有的表决权数量 | 21,634,885 | | 普通股股东所持有表决权数量 | 21,634,885 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 15.7908 | | 例（%） | | | 普通股股东所持有表决权数量占公司表决权数量的比例（%） | 15.7908 | （四） ...

北京市中伦律师事务所 关于奥精医疗科技股份有限公司 2025 年第二次临时股东大会的 在本法律意见书中，本所律师仅对本次股东大会的召集、召开程序、出席本 次股东大会人员和召集人的资格、会议表决程序及表决结果是否符合《公司法》 《股东会规则》等相关法律、法规、规章、规范性文件及《公司章程》的规定发 表意见，并不对会议审议的议案内容以及该等议案所表述的事实或数据的真实性 及准确性发表意见。本所仅根据现行有效的中国法律问题发表意见，而未对有关 会计、审计和资产评估等非法律专业事项发表意见，亦未对非中国法律问题发表 意见。 本所同意将本法律意见书作为本次股东大会的公告材料，随同其他会议文件 一并报送有关机构并公告。本法律意见书仅供公司为本次股东大会之目的而使用， 未经本所书面同意，本法律意见书不得用于任何其他目的。 基于上述，本所律师按照律师行业公认的业务标准、道德规范和勤勉尽责的 精神，对公司所提供的相关文件和有关事实进行了核查和验证，现出具法律意见 如下： 致：奥精医疗科技股份有限公司 北京市中伦律师事务所（以下简称"本所"）接受奥精医疗科技股份有限公 司（以下简称"公司"）委托，指派律师见证公司 2025 年第 ...

Group 1 - A total of 67 stocks experienced block trading on September 15, with a total transaction value of 2.22 billion yuan [1] - The top three stocks by transaction value were Hangzhou Steel (2.5 billion yuan), Guangqi Technology (2.23 billion yuan), and Demingli (2.04 billion yuan) [1] - Among the stocks, 10 were traded at par, 4 at a premium, and 53 at a discount; Zhejiang Meida, SF Holding, and HNA Technology had the highest premium rates of 9.04%, 7.06%, and 1.35% respectively [1] Group 2 - The top stocks by institutional buying were Hangzhou Steel (250 million yuan), Jiangsu Leili (198 million yuan), and Haiguang Information (106 million yuan) [2] - Other notable institutional purchases included Caida Securities (63.6 million yuan), BGI (25 million yuan), and Ningde Times (20.9 million yuan) [2] Group 3 - The top stocks by institutional selling included Xinyi Technology (21 million yuan), Ningde Times (20.9 million yuan), and BYD (20.8 million yuan) [3]

Summary of Key Points Core Viewpoint - On September 15, Aojing Medical executed a block trade of 350,000 shares, amounting to a transaction value of 9.2085 million yuan, which represented 2.67% of the total trading volume for that day. The transaction price was 26.31 yuan, reflecting a discount of 1.5% compared to the market closing price of 26.71 yuan [1]. Group 1 - The block trade involved 350,000 shares of Aojing Medical, with a total transaction value of 9.2085 million yuan [1]. - The transaction price of 26.31 yuan was lower than the market closing price, indicating a discount of 1.5% [1]. - The trade accounted for 2.67% of the total trading volume on that day [1]. Group 2 - The trade was executed by an institutional investor through Huatai Securities [2]. - The transaction occurred on September 15, 2025, under the stock code 688613 [2]. - The trading volume and price details were specifically recorded, highlighting the institutional nature of the transaction [2].

截至2025年9月12日收盘，奥精医疗(688613)报收于26.03元，下跌3.38%，换手率5.63%，成交量7.72万 手，成交额2.02亿元。 当日关注点 大宗交易 9月12日奥精医疗现1笔大宗交易，机构净买入765.3万元。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 来自交易信息汇总：9月12日主力资金净流入209.93万元，占总成交额0.79%。 来自交易信息汇总：当日奥精医疗发生1笔大宗交易，机构净买入765.3万元。 交易信息汇总资金流向 9月12日主力资金净流入209.93万元，占总成交额0.79%；游资资金净流出357.21万元，占总成交额 1.34%；散户资金净流入147.28万元，占总成交额0.55%。 ...

Group 1 - The core transaction on September 12 involved a block trade of 300,000 shares of Aojing Medical, with a transaction value of 7.653 million yuan, at a price of 25.51 yuan, which represents a discount of 1.51% compared to the closing price of the day [2][3] - Over the past three months, Aojing Medical has recorded a total of five block trades, amounting to a cumulative transaction value of 36.216 million yuan [3] - On the same day, Aojing Medical's closing price was 25.90 yuan, reflecting a decline of 3.86%, with a turnover rate of 7.44% and a total trading volume of 266 million yuan, indicating a net outflow of 2.4371 million yuan in main funds [3] Group 2 - The latest margin financing balance for Aojing Medical is 155 million yuan, which has increased by 5.6297 million yuan over the past five days, representing a growth rate of 3.77% [3]

Group 1 - The stock price of Aojing Medical (688613) closed at 26.94 yuan on September 11, 2025, with an increase of 5.98% [1] - The trading volume was 141,400 lots, resulting in a total transaction amount of 374 million yuan [1] Group 2 - On September 11, the net inflow of main funds was 34.11 million yuan, accounting for 9.11% of the total transaction amount [2][3] - Retail investors experienced a net outflow of 27.05 million yuan, representing 7.22% of the total transaction amount [2] - There was one block trade on September 11, with institutional net purchases amounting to 10.616 million yuan [2][3]